The analysis revealed that SH3BP5 is preferentially overexpressed in the ABC subtype of DLBCL across multiple datasets and validated cohorts, and its high expression is significantly associated with poor overall survival. This evidence concerns the gene SH3BP5 and diffuse large B-cell lymphoma.